American Association for the Advancement of Science, Science Translational Medicine, 387(9), 2017
DOI: 10.1126/scitranslmed.aal3986
Full text: Unavailable
The concomitant use of CDK4/6 inhibitors with cytotoxic agents may prevent chemotherapy-induced bone marrow exhaustion in cancer patients.